Artículos

Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans / Melanie G. Byers en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 225-229 Título : Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans : An assessment of long-term comparative effectiveness and safety Tipo de documento: texto impreso Autores: Melanie G. Byers, Autor ; Kristen M. Allison, Autor Fecha de publicación: 2022 Artículo en la página: pp. 225-229 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno de estrés postraumático, Síntomas nocturnos, Prazosina, Quetiapina, Antagonista adrenérgico, Antipsicótico atípico Resumen: Posttraumatic stress disorder (PTSD) is an anxiety disorder experienced by combat veterans. Nighttime symptoms are often unrelieved by selective serotonin reuptake inhibitor therapy, and increased use of prazosin or quetiapine for treatment is seen. Link: ./index.php?lvl=notice_display&id=29445 [artículo] Prazosin versus quetiapine for nighttime posttraumatic stress disorder symptoms in veterans : An assessment of long-term comparative effectiveness and safety [texto impreso] / Melanie G. Byers, Autor ; Kristen M. Allison, Autor . - 2022 . - pp. 225-229. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 225-229 Palabras clave: Trastorno de estrés postraumático, Síntomas nocturnos, Prazosina, Quetiapina, Antagonista adrenérgico, Antipsicótico atípico Resumen: Posttraumatic stress disorder (PTSD) is an anxiety disorder experienced by combat veterans. Nighttime symptoms are often unrelieved by selective serotonin reuptake inhibitor therapy, and increased use of prazosin or quetiapine for treatment is seen. Link: ./index.php?lvl=notice_display&id=29445

Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in taiwan / Wen Yu Hsu en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 230-234 Título : Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in taiwan Tipo de documento: texto impreso Autores: Wen Yu Hsu, Autor ; Si Sheng Huang, Autor ; Bo Shyan Lee, Autor Fecha de publicación: 2022 Artículo en la página: pp. 230-234 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Olanzapina, Haloperidol, Risperidona, Agitación, Inyección, Vía oral Resumen: The purpose of this study was to compare efficacy and safety among intramuscular olanzapine, intramuscular haloperidol, orally disintegrating olanzapine tablets, and oral risperidone solution for agitated patients with psychosis during the first 24 hours of treatment in an acute care psychiatric ward. Link: ./index.php?lvl=notice_display&id=29446 [artículo] Comparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in taiwan [texto impreso] / Wen Yu Hsu, Autor ; Si Sheng Huang, Autor ; Bo Shyan Lee, Autor . - 2022 . - pp. 230-234. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 230-234 Palabras clave: Olanzapina, Haloperidol, Risperidona, Agitación, Inyección, Vía oral Resumen: The purpose of this study was to compare efficacy and safety among intramuscular olanzapine, intramuscular haloperidol, orally disintegrating olanzapine tablets, and oral risperidone solution for agitated patients with psychosis during the first 24 hours of treatment in an acute care psychiatric ward. Link: ./index.php?lvl=notice_display&id=29446

A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia / Gahan J. Pandina en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 235-244 Título : A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia Tipo de documento: texto impreso Autores: Gahan J. Pandina, Autor ; Jean-Pierre Lindenmayer, Autor ; Julia Lull, Autor Fecha de publicación: 2022 Artículo en la página: pp. 235-244 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicótico atípico, Deltoides, Dosis de inicio, Inyectable de acción prolongada, Palmitato de paliperidona, Esquizofrenia Resumen: This study assessed the efficacy and the safety of a dosing regimen that was revised from earlier studies for the investigational injectable atypical antipsychotic paliperidone palmitate (approved in the USA, August 2009) for adult patients with acutely exacerbated schizophrenia. Link: ./index.php?lvl=notice_display&id=29447 [artículo] A randomized, placebo-controlled study to assess the efficacy and safety of 3 doses of paliperidone palmitate in adults with acutely exacerbated schizophrenia [texto impreso] / Gahan J. Pandina, Autor ; Jean-Pierre Lindenmayer, Autor ; Julia Lull, Autor . - 2022 . - pp. 235-244. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 235-244 Palabras clave: Antipsicótico atípico, Deltoides, Dosis de inicio, Inyectable de acción prolongada, Palmitato de paliperidona, Esquizofrenia Resumen: This study assessed the efficacy and the safety of a dosing regimen that was revised from earlier studies for the investigational injectable atypical antipsychotic paliperidone palmitate (approved in the USA, August 2009) for adult patients with acutely exacerbated schizophrenia. Link: ./index.php?lvl=notice_display&id=29447

Effects of cholinesterase inhibitors on visual attention in drivers with alzheimer disease / Lori A. Daiello en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 245-251 Título : Effects of cholinesterase inhibitors on visual attention in drivers with alzheimer disease Tipo de documento: texto impreso Autores: Lori A. Daiello, Autor ; Brian R. Ott, Autor ; Elena K. Festa, Autor Fecha de publicación: 2022 Artículo en la página: pp. 245-251 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos cognitivos, Demencia, Enfermedad de Alzheimer, Inhibidores de la colinesterasa, Atención, Conducción Resumen: We conducted a combined observational cohort and case-control study in patients with Alzheimer disease (AD) to assess the effects of acetylcholinesterase inhibitor (ChEI) treatment on cognitive functions important for driving. Link: ./index.php?lvl=notice_display&id=29448 [artículo] Effects of cholinesterase inhibitors on visual attention in drivers with alzheimer disease [texto impreso] / Lori A. Daiello, Autor ; Brian R. Ott, Autor ; Elena K. Festa, Autor . - 2022 . - pp. 245-251. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 245-251 Palabras clave: Trastornos cognitivos, Demencia, Enfermedad de Alzheimer, Inhibidores de la colinesterasa, Atención, Conducción Resumen: We conducted a combined observational cohort and case-control study in patients with Alzheimer disease (AD) to assess the effects of acetylcholinesterase inhibitor (ChEI) treatment on cognitive functions important for driving. Link: ./index.php?lvl=notice_display&id=29448

Risk of ischemic stroke associated with antidepressant drug use in elderly persons / Gianluca Trifirò en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 252-258 Título : Risk of ischemic stroke associated with antidepressant drug use in elderly persons Tipo de documento: texto impreso Autores: Gianluca Trifirò, Autor ; Jeanne Dieleman, Autor ; Elif F. Sen, Autor Fecha de publicación: 2022 Artículo en la página: pp. 252-258 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Fármaco antidepresivo, Ictus, Isquemia cerebral Resumen: Competing hypotheses have been formulated about a possible association between selective serotonin reuptake inhibitors (SSRIs) and ischemic stroke. However, the relationship between antidepressant drug use and ischemic stroke is still unclear. The aim of the study was to assess the association between the use of different types of antidepressants and the risk of ischemic stroke in elderly outpatients. Link: ./index.php?lvl=notice_display&id=29449 [artículo] Risk of ischemic stroke associated with antidepressant drug use in elderly persons [texto impreso] / Gianluca Trifirò, Autor ; Jeanne Dieleman, Autor ; Elif F. Sen, Autor . - 2022 . - pp. 252-258. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 252-258 Palabras clave: Fármaco antidepresivo, Ictus, Isquemia cerebral Resumen: Competing hypotheses have been formulated about a possible association between selective serotonin reuptake inhibitors (SSRIs) and ischemic stroke. However, the relationship between antidepressant drug use and ischemic stroke is still unclear. The aim of the study was to assess the association between the use of different types of antidepressants and the risk of ischemic stroke in elderly outpatients. Link: ./index.php?lvl=notice_display&id=29449

Early adverse events and attrition in selective serotonin reuptake inhibitor treatment / Diane Warden en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 259-266 Título : Early adverse events and attrition in selective serotonin reuptake inhibitor treatment : A suicide assessment methodology study report Tipo de documento: texto impreso Autores: Diane Warden, Autor ; Madhukar H. Trivedi, Autor ; Stephen R. Wisniewski, Autor Fecha de publicación: 2022 Artículo en la página: pp. 259-266 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Deserción, Adherencia, Eventos adversos, Antidepresivo, Depresión Resumen: Adverse events during selective serotonin reuptake inhibitor (SSRI) treatment are frequent and may lead to premature treatment discontinuation. If attrition is associated with early worsening of adverse effects or the frequency, intensity, or burden of adverse effects, interventions to maximize retention could be focused on patients with these events. Link: ./index.php?lvl=notice_display&id=29450 [artículo] Early adverse events and attrition in selective serotonin reuptake inhibitor treatment : A suicide assessment methodology study report [texto impreso] / Diane Warden, Autor ; Madhukar H. Trivedi, Autor ; Stephen R. Wisniewski, Autor . - 2022 . - pp. 259-266. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 259-266 Palabras clave: Deserción, Adherencia, Eventos adversos, Antidepresivo, Depresión Resumen: Adverse events during selective serotonin reuptake inhibitor (SSRI) treatment are frequent and may lead to premature treatment discontinuation. If attrition is associated with early worsening of adverse effects or the frequency, intensity, or burden of adverse effects, interventions to maximize retention could be focused on patients with these events. Link: ./index.php?lvl=notice_display&id=29450

Long-term follow-up study of patients with serotonin reuptake inhibitor-nonresponsive obsessive-compulsive disorder / YC Janardhan Reddy en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 267-272 Título : Long-term follow-up study of patients with serotonin reuptake inhibitor-nonresponsive obsessive-compulsive disorder Tipo de documento: texto impreso Autores: YC Janardhan Reddy, Autor ; Adarsha M. Alur, Autor ; Smitha Manjunath, Autor Fecha de publicación: 2022 Artículo en la página: pp. 267-272 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastorno obsesivo compulsivo, Falta de respuesta al tratamiento, Falta de respuesta al SRI, Seguimiento Resumen: There is a paucity of data on the long-term outcome of serotonin reuptake inhibitor (SRI)-nonresponsive obsessive-compulsive disorder (OCD). We report long-term outcome of OCD in subjects who had not responded to at least 2 adequate trials of SRIs. Link: ./index.php?lvl=notice_display&id=29451 [artículo] Long-term follow-up study of patients with serotonin reuptake inhibitor-nonresponsive obsessive-compulsive disorder [texto impreso] / YC Janardhan Reddy, Autor ; Adarsha M. Alur, Autor ; Smitha Manjunath, Autor . - 2022 . - pp. 267-272. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 267-272 Palabras clave: Trastorno obsesivo compulsivo, Falta de respuesta al tratamiento, Falta de respuesta al SRI, Seguimiento Resumen: There is a paucity of data on the long-term outcome of serotonin reuptake inhibitor (SRI)-nonresponsive obsessive-compulsive disorder (OCD). We report long-term outcome of OCD in subjects who had not responded to at least 2 adequate trials of SRIs. Link: ./index.php?lvl=notice_display&id=29451

Two-year outcome of vagus nerve stimulation in treatment resistant depression / Malek Bajbouj en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 273-281 Título : Two-year outcome of vagus nerve stimulation in treatment resistant depression Tipo de documento: texto impreso Autores: Malek Bajbouj, Autor ; Angela Merkl, Autor ; Thomas E. Schlaepfer, Autor Fecha de publicación: 2022 Artículo en la página: pp. 273-281 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Ensayo clínico, Escala de calificación de Hamilton para la depresión, Trastorno depresivo mayor, Depresión, Estimulación del nervio vago Resumen: One of the major goals of antidepressant treatment is a sustained response and remission of depressive symptoms. Some of the previous studies of vagus nerve stimulation (VNS) have suggested antidepressant effects. Our naturalistic study assessed the efficacy and the safety of VNS in 74 European patients with therapy-resistant major depressive disorder. Link: ./index.php?lvl=notice_display&id=29452 [artículo] Two-year outcome of vagus nerve stimulation in treatment resistant depression [texto impreso] / Malek Bajbouj, Autor ; Angela Merkl, Autor ; Thomas E. Schlaepfer, Autor . - 2022 . - pp. 273-281. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 273-281 Palabras clave: Ensayo clínico, Escala de calificación de Hamilton para la depresión, Trastorno depresivo mayor, Depresión, Estimulación del nervio vago Resumen: One of the major goals of antidepressant treatment is a sustained response and remission of depressive symptoms. Some of the previous studies of vagus nerve stimulation (VNS) have suggested antidepressant effects. Our naturalistic study assessed the efficacy and the safety of VNS in 74 European patients with therapy-resistant major depressive disorder. Link: ./index.php?lvl=notice_display&id=29452

Hematological effects of valproate in psychiatric patients / Kamini Vasudev en Journal of Clinical Psychopharmacology, Año 2010 - Vol. 30 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 282-285 Título : Hematological effects of valproate in psychiatric patients : What are the risk factors? Tipo de documento: texto impreso Autores: Kamini Vasudev, Autor ; Patrick Keown, Autor ; Ian Gibb, Autor Fecha de publicación: 2022 Artículo en la página: pp. 282-285 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Valproato, Hematológico, Trombocitopenia, Trastorno bipolar, VCM. Resumen: Sodium valproate is an anticonvulsant that is also one of the common treatments used for bipolar disorder. The present study was conducted in psychiatric patients with the aim of examining the effects of valproate on hematological parameters and to explore any association with sex and age. Link: ./index.php?lvl=notice_display&id=29453 [artículo] Hematological effects of valproate in psychiatric patients : What are the risk factors? [texto impreso] / Kamini Vasudev, Autor ; Patrick Keown, Autor ; Ian Gibb, Autor . - 2022 . - pp. 282-285. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2010 - Vol. 30 - No. 3 (Junio) . - pp. 282-285 Palabras clave: Valproato, Hematológico, Trombocitopenia, Trastorno bipolar, VCM. Resumen: Sodium valproate is an anticonvulsant that is also one of the common treatments used for bipolar disorder. The present study was conducted in psychiatric patients with the aim of examining the effects of valproate on hematological parameters and to explore any association with sex and age. Link: ./index.php?lvl=notice_display&id=29453